Share Share on Facebook LinkedIn Share on Twitter Four states legalized recreational marijuana in November, nearly doubling the number of states where recreational pot is legal. As more states consider joining them, a range of arguments for and against legalization is swirling around the national conversation.But which of these arguments resonate most strongly with Americans? It’s the arguments that support legalization, according to a new study co-authored by Jeff Niederdeppe, associate professor of communication in Cornell University’s College of Agriculture and Life Sciences.More than 60 percent of people surveyed in the study said they supported legalization because they agreed with arguments saying it would increase tax revenues, create a profitable new industry, reduce prison crowding and lower the cost of law enforcement. Email Pinterest In contrast, fewer people in the study agreed with anti-legalization arguments emphasizing the damage the policy would have on public health. These reasons included that legalization would increase car accidents, hurt youth’s health, expand the marijuana industry, increase crime and threaten moral values.“The pro arguments are really practical: ‘Give us money and jobs. Keep our prison from being overcrowded, make law enforcement’s job easier,’” said Niederdeppe. “And the con arguments are a little more ideological: ‘This is going to lead to big industry and crime and undermine the fundamental values that make America great.’”“Public perceptions of arguments supporting and opposing recreational marijuana legalization” appeared in Preventive Medicine.
Dr Jean Damascene Makuza, the acting director of Viral Hepatitis and STI Unit at Rwanda Biomedical Centre, said the exercise will be implemented in districts that weren’t reached. Image courtesy: The New Times Dr Jean Damascene Makuza, the acting director of Viral Hepatitis and STI Unit at Rwanda Biomedical Centre, said the exercise will be implemented in districts that weren’t reached. Image courtesy: The New TimesRwanda’s Ministry of Health has concluded a campaign on prevention, access to testing, treatment and care of Hepatitis.Concluding last Friday, the campaign was conducted in line with World Hepatitis Day (WHD) celebrations. According to local media, during the campaign, 250,000 people were expected to be screened for Hepatitis B and C while 400,000 (over 15 years old) would be freely vaccinated against Hepatitis B.Dr Jean Damascene Makuza, the acting director of Viral Hepatitis and STI Unit at Rwanda Biomedical Centre, said the exercise will be implemented in districts that weren’t reached.“We plan to reach all districts but we have so far covered 12 districts. Due to the presidential campaigns, the exercise has been postponed and the remaining 18 districts will be attended to later,” he told The New Times.Dr Makuza said, about 210,000 people have so far been vaccinated while about 100,000 have been screened countrywide.Discussing the Hepatitis prevalence in Rwanda, Makuza said that it was hard at the moment to determine whether the disease was on the rise or not.Experts have been concerned that although the campaign offered screenings for a large number of people, it fell well short of reaching the national number.Makuza added that the prevalence among the people above 15 years is between 3 and 4 per cent for both Hepatitis B and C.Most vulnerable groups include medics, sex workers, and prisoners, among others.There are also efforts by the government to reduce the cost of HBV vaccinations – which is still seen as unaffordable to many.“During the campaign, we noticed that many people were willing to get tested and vaccinated as a result of increased sensitisation,” Makuza told The New Times.“We are going to have negotiations with our donors and partners to cut the price from Rwf 8, 700 to at least Rwf2,000 or Rwf3,000.“Ministries, private insurance companies and other partners are coming together to see how we can help in make such services more affordable,” he added.According to Global Hepatitis Report 2017, an estimated 325 million people are living with chronic hepatitis infections (HBV or HCV) worldwide.Viral hepatitis caused 1.34 million deaths in 2015, a number that is comparable to deaths caused by tuberculosis and higher than deaths caused by HIV.A vaccine against hepatitis B has been available since 1982 but research is still ongoing to find vaccine for hepatitis C though it can be treated and cured.